IJCM  Vol.5 No.5 , March 2014
Review: Do We Still Need a Viability Study before Considering Revascularization in Patient with Stable Coronary Artery Disease and Significant Left Ventricular Systolic Dysfunction?
ABSTRACT

Patients with ischemic cardiomyopathy constitute a heterogeneous group of patients with an extremely complex condition in which many factors play an important prognostic role. So it is difficult and probably unrealistic to expect that a single feature like presence of viable myocardium would provide an unequivocal answer to a critical question of revasculrization or not for all patients. Opposite to the hopes of investigators and physicians involved in the care of these patients, the findings of prospective studies with the use of different viability testing methods did not help in the decision-making process regarding CABG in ischemic cardiomyopathy. Instead, they left us with the same dilemma. The implication of most of these trials is that in patients with CAD and significant LV dysfunction, assessment of myocardial viability does not identify patients who will have the greatest survival benefit from adding CABG to aggressive medical therapy. In the clinical practice, these observations remind physicians to consider the multiplicity of factors involved in the decision-making process for patients with such a complex disease.


Cite this paper
Albackr, H. , Al Mobeirek, A. , Shamiri, M. and Albacker, T. (2014) Review: Do We Still Need a Viability Study before Considering Revascularization in Patient with Stable Coronary Artery Disease and Significant Left Ventricular Systolic Dysfunction?. International Journal of Clinical Medicine, 5, 242-248. doi: 10.4236/ijcm.2014.55038.
References
[1]   American Heart Association (2006) Heart Disease and Stroke Statistics. American Heart Association.

[2]   Gheorghiade, M. and Bonow, R.O. (1998) Chronic Heart Failure in the United States: A Manifestation of Coronary Artery Disease. Circulation, 97, 282-289. http://dx.doi.org/10.1161/01.CIR.97.3.282

[3]   Levy, D., Kenchaiah, S., Larson, M.G., et al. (2002) Long-Term Trends in the Incidence of and Survival with Heart Failure. New England Journal of Medicine, 347, 1397-1402. http://dx.doi.org/10.1056/NEJMoa020265

[4]   Schinkel, A.F.L., Poldermans, D., Vanoverschelde, J.L.J., et al. (2004) Incidence of Recovery of Contractile Function Following Revascularization in Patients with Ischemic Left Ventricular Dysfunction. American Journal of Cardiology, 93, 14-17. http://dx.doi.org/10.1016/j.amjcard.2003.09.005

[5]   Rahimtoola, S.H. (19890 The Hibernating Myocardium. American Heart Journal, 117, 211-221.
http://dx.doi.org/10.1016/0002-8703(89)90685-6

[6]   Heyndrickx, G.R., Millard, R.W., McRitchie, R.J., Maroko, P.R. and Vatner, F. (1975) Regional Myocardial Functional and Electrophysiological Alterations after Brief Coronary Artery Occlusion in Conscious Dogs. Journal of Clinical Investigation, 56, 978-985. http://dx.doi.org/10.1172/JCI108178

[7]   Braunwald, E. and Kloner, R.A. (1982) The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction. Circulation, 66, 1146-1149. http://dx.doi.org/10.1161/01.CIR.66.6.1146

[8]   Bonow, R.O. (1999) Contractile Reserve and Coronary Blood Flow Reserve in Collateral Dependent Myocardium. Journal of the American College of Cardiology, 33, 705-707.

[9]   Bax, J.J., Poldermans, D., Elhendy, A., Boersma, E. and Rahimtoola, S.H. (2001) Sensitivity, Specificity, and Predictive Accuracies of Various Noninvasive Techniques for Detecting Hibernating Myocardium. Current Problems in Cardiology, 26, 142-186. http://dx.doi.org/10.1067/mcd.2001.109973

[10]   DiCarli, M.F., Asgarzadie, F., Schelbert, H.R., et al. (1995) Quantitative Relation between Myocardial Viability and Improvement in Heart Failure Symptoms after Revascularization in Patients with Ischemic Cardiomyopathy. Circulation, 92, 3436-3444. http://dx.doi.org/10.1161/01.CIR.92.12.3436

[11]   Bax, J.J., Visser, F.C., Poldermans, D., et al. (2001) Relationship between Preoperative Viability and Postoperative Improvement in LVEF and Heart Failure Symptoms. Journal of Nuclear Medicine, 42, 79-86.

[12]   Marwick, T.H., Zuchowski, C., Lauer, M.S., Secknus, M.A., Williams, M.J. and Lytle, B.W. (1999) Functional Status and Quality of Life in Patients with Heart Failure Undergoing Coronary Bypass Surgery after Assessment of Myocardial Viability. Journal of the American College of Cardiology, 33, 750-758.
http://dx.doi.org/10.1016/S0735-1097(98)00642-1

[13]   Mule, J., Bax, J.J., Zingone, B., et al. (2002) The Beneficial Effect of Revascularization on Jeopardized Myocardium: Reverse Remodeling and Improved Long-Term Prognosis. European Journal Cardio-Thoracic Surgery, 22, 426-430.
http://dx.doi.org/10.1016/S1010-7940(02)00359-7

[14]   Rohatgi, R., Epstein, S., Henriquez, J., et al. (2001) Utility of Positron Emission Tomography in Predicting Cardiac Events and Survival in Patients with Coronary Artery Disease and Severe Left Ventricular Dysfunction. American Journal of Cardiology, 87, 1096-1099. http://dx.doi.org/10.1016/S0002-9149(01)01468-0

[15]   Allman, K.C., Shaw, L.J., Hachamovitch, R. and Udelson, J.E. (2002) Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: A MetaAnalysis. Journal of the American College of Cardiology, 39, 1151-1158.
http://dx.doi.org/10.1016/S0735-1097(02)01726-6

[16]   Allman, K.C., Shaw, L.J., Hachamovitch, R. and Udelson, J.E. (2002) Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: A Metaanalysis. Journal of the American College of Cardiology, 39, 1151-1158.
http://dx.doi.org/10.1016/S0735-1097(02)01726-6

[17]   Chareonthaitawee, P., Gersh, B.J., Araoz, P.A. and Gibbons, R.J. (2005) Revascularization in Severe Left Ventricular Dysfunction: the Role of Viability Testing. Journal of the American College of Cardiology, 46, 567-574.
http://dx.doi.org/10.1016/j.jacc.2005.03.072

[18]   Schinkel, A.F., Bax, J.J., Poldermans, D., Elhendy, A., Ferrari, R. and Rahimtoola, S.H. (2007) Hibernating Myocardium: Diagnosis and Patient Outcomes. Current Problems in Cardiology, 32, 375-410.
http://dx.doi.org/10.1016/j.cpcardiol.2007.04.001

[19]   Camici, P.G., Prasad, S.K. and Rimoldi, O.E. (2008) Stunning, Hibernation, and Assessment of Myocardialviability. Circulation, 117, 103-114. http://dx.doi.org/10.1016/j.cpcardiol.2007.04.001

[20]   Hillis, L.D., Smith, P.K., Anderson, J.L., et al. (2011) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 58, e123-e210.
http://dx.doi.org/10.1016/j.jacc.2011.08.009

[21]   Beanlands, R.S., Nichol, G., Huszti, E., et al., for the PARR-2 Investigators (2007) F-18-Fluorodeoxyglucose Positron Emission Tomography Imagingassisted Management of Patients with Severe Left Ventricular Dysfunction and Suspected Coronary Disease: A Randomized, Controlled Trial (PARR-2). Journal of the American College of Cardiology, 50, 2002-2012. http://dx.doi.org/10.1016/j.jacc.2007.09.006

[22]   Cleland, J.G.F., Calvert, M., Freemantle, N., et al. (2011) The Heart Failure Revascularisation Trial (HEART). European Journal of Heart Failure, 13, 227-233. http://dx.doi.org/10.1093/eurjhf/hfq230

[23]   Velazquez, E.J., Lee, K.L., Deja, M.A., et al., for the STICH Investigators (2011) Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. The New England Journal of Medicine, 364, 1607-1616.
http://dx.doi.org/10.1056/NEJMoa1100356

[24]   Bonow, R.O., Maurer, G., Lee, K.L., et al., for the STICH Investigators (2011) Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction. The New England Journal of Medicine, 364, 1617-1625.
http://dx.doi.org/10.1056/NEJMoa1100358

[25]   Schinkel, A.F., Bax, J.J., Poldermans, D., Elhendy, A., Ferrari, R. and Rahimtoola, S.H. (2007) Hibernating Myocardium: Diagnosis and Patient Outcomes. Current Problems in Cardiology, 32, 375-410.
http://dx.doi.org/10.1016/j.cpcardiol.2007.04.001

[26]   Al-Mohammad, A., Mahy, I.R., Norton, M.Y., et al. (1998) Prevalence of Hibernating Myocardium in Patients with Severely Impaired Ischaemic Left Ventricles. Heart, 80, 559-564.

[27]   Auerbach, M.A., Schöder, H., Gambhir, S.S., et al. (1999) Prevalence of Myocardial Viability as Detected by Positron Emission Tomography in Patients with Ischemic Cardiomyopathy. Circulation, 99, 2921-2926.
http://dx.doi.org/10.1161/01.CIR.99.22.2921

[28]   Schinkel, A.F.L., Bax, J.J., Sozzi, F.B., et al. (2002) Prevalence of Myocardial Viability Assessed by Single Photon Emission Computed Tomography in Patients with Chronic Ischaemic Left Ventricular Dysfunction. Heart, 88, 125-130.
http://dx.doi.org/10.1136/heart.88.2.125

[29]   Schinkel, A.F.L., Bax, J.J., Boersma, E., Elhendy, A., Roelandt, J.R.T.C. and Poldermans, D. (2001) How Many Patients with Ischemic Cardiomyopathy Exhibit Viable Myocardium? American Journal of Cardiology, 88, 561-564.
http://dx.doi.org/10.1016/S0002-9149(01)01741-6

[30]   Stipac, A.V., Stankovic, I., Vidakovic, R., Putnikovic, B., Ilic, I., Milicic, B. and Neskovic, A.N. (2013) Effect of Myocardial Revascularisation on Left Ventricular Systolic Function in Patients with and without Viable Myocardium: Should Non-Viable Segments Be Revascularised? Heart, 99, 1749-1754.
http://dx.doi.org/10.1136/heartjnl-2013-304288

[31]   Shah, D.J., Kim, H.W., James, O., Parker, M., Wu, E., Bonow, R.O., Judd, R.M. and Kim, R.J. (2013) Prevalence of Regional Myocardial Thinning and Relationship with Myocardial Scarring in Patients with Coronary Artery Disease. JAMA, 309, 909-918. http://dx.doi.org/10.1001/jama.2013.1381

 
 
Top